Stem cell plasticity, cell fusion, and transdifferentiation
β Scribed by Leonard M. Eisenberg; Carol A. Eisenberg
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 404 KB
- Volume
- 69
- Category
- Article
- ISSN
- 1542-975X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
One of the most contentious issues in biology today concerns the existence of stem cell plasticity. The term βplasticityβ refers to the capacity of tissueβderived stem cells to exhibit a phenotypic potential that extends beyond the differentiated cell phenotypes of their resident tissue. Although evidence of stem cell plasticity has been reported by multiple laboratories, other scientists have not found the data persuasive and have remained skeptical about these new findings. This review will provide an overview of the stem cell plasticity controversy. We will examine many of the major objections that have been made to challenge the stem cell plasticity data. This controversy will be placed in the context of the traditional view of stem cell potential and cell phenotypic diversification. What the implications of cell plasticity are, and how its existence may modulate our present understanding of stem cell biology, will be explored. In addition, we will examine a topic that is usually not included within a discussion of stem cell biologyβthe direct conversion of one differentiated cell type into another. We believe that these observations on the transdifferentiation of differentiated cells have direct bearing on the issue of stem cell plasticity, and may provide insights into how cell phenotypic diversification is realized in the adult and into the origin of cell phenotypes during evolution. Birth Defects Research (Part C) 69:209β218, 2003. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
The pancreas is composed of at least three types of differentiated tissue: the hormone-containing cells in islets (4 different cell types), the exocrine zymogen-containing acini, and the centroacinar cells, ductules and ducts (ductal tree). All of these cells appear to have a common origin during em
## Abstract Cell therapy can offer a reasonable approach to the treatment of specific birth defects, particularly those for which hematopoietic stem cells (HSCs) can be used to restore (even partially) the number of cells, protein levels, or enzyme activity. Relatively few clinical experiences have
## Abstract This article continues the Journal's 2005 series of leaders highlighting areas where laboratory science meets clinical practice. In it Dr Holger Willenbring of the Oregon Stem Cell Center discusses the promise of therapeutic cell fusion and the difficulties that remain in bringing this